Literature DB >> 8585751

First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains.

J Lemozy1, D Sirot, C Chanal, C Huc, R Labia, H Dabernat, J Sirot.   

Abstract

Two clinical strains of Klebsiella pneumoniae, TP 01 and TP 02, presented resistance to amoxicillin-clavulanate and were fully susceptible to cephalothin. These strains produced two beta-lactamases, SHV-1 and a TEM enzyme with a pI of 5.2. The previously described changes Arg-244-->Cys and Arg-244-->Ser in IRT-1 and IRT-2 (A. Belaaouaj, C. Lapoumeroulie, M. M. Caniça, G. Vedel, P. Nevot, R. Krishnamoorthy, and G. Paul, FEMS Microbiol. Lett. 120:75-80, 1994) were found in TEM enzymes from the TP 01 and TP 02 strains, respectively. This is the first report of inhibitor-resistant TEM (IRT) in species other than Escherichia coli from the family Enterobacteriaceae.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8585751      PMCID： PMC162990          DOI： 10.1128/AAC.39.11.2580

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

1.  Beta-lactamase TEM1 of E. coli. Crystal structure determination at 2.5 A resolution.

Authors:  C Jelsch; F Lenfant; J M Masson; J P Samama
Journal:  FEBS Lett       Date:  1992-03-09       Impact factor: 4.124

2.  A standard numbering scheme for the class A beta-lactamases.

Authors:  R P Ambler; A F Coulson; J M Frère; J M Ghuysen; B Joris; M Forsman; R C Levesque; G Tiraby; S G Waley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

3.  Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli.

Authors:  J L Martinez; M F Vicente; A Delgado-Iribarren; J C Perez-Diaz; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

4.  Sequence of the genes blaT-1B and blaT-2.

Authors:  S Goussard; P Courvalin
Journal:  Gene       Date:  1991-06-15       Impact factor: 3.688

5.  Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of beta-lactamase in Pseudomonas aeruginosa and Escherichia coli.

Authors:  S T Chen; R C Clowes
Journal:  J Bacteriol       Date:  1987-02       Impact factor: 3.490

6.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

7.  Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli.

Authors:  J A Reguera; F Baquero; J C Pérez-Díaz; J L Martínez
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

Review 8.  Extended-spectrum plasmid-mediated beta-lactamases.

Authors:  D Sirot
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  An efficient method for generating proteins with altered enzymatic properties: application to beta-lactamase.

Authors:  A R Oliphant; K Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205
View more
  22 in total

1.  What's New in beta-lactamases?

Authors:  Patricia A. Bradford
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

2.  TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.

Authors:  C Neuwirth; S Madec; E Siebor; A Pechinot; J M Duez; M Pruneaux; M Fouchereau-Peron; A Kazmierczak; R Labia
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.

Authors:  Sergei Vakulenko; Dasantila Golemi
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 4.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

5.  Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.

Authors:  Oren Zimhony; Inna Chmelnitsky; Rita Bardenstein; Sorel Goland; Orly Hammer Muntz; Shiri Navon Venezia; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

6.  SHV-49, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Klebsiella pneumoniae.

Authors:  Véronique Dubois; Laurent Poirel; Corinne Arpin; Laure Coulange; Cécile Bebear; Patrice Nordmann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.

Authors:  Véronique Dubois; Laurent Poirel; François Demarthe; Corinne Arpin; Laure Coulange; Luciene A R Minarini; Marie-Christine Bezian; Patrice Nordmann; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

8.  Analysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 beta-lactamase.

Authors:  David C Marciano; Nicholas G Brown; Timothy Palzkill
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

Review 9.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

10.  Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase.

Authors:  David C Marciano; Jeanine M Pennington; Xiaohu Wang; Jian Wang; Yu Chen; Veena L Thomas; Brian K Shoichet; Timothy Palzkill
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.